Yarrow Bioscience (YARW) Research & Development (2017 - 2026)

Yarrow Bioscience (YARW) has reported Research & Development for 10 consecutive years, with $788000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 83.86% year-over-year to $788000.0; the trailing twelve-month figure through Jun 2026 stood at $12.6 million (down 59.24% YoY), and the FY2025 full-year result was $19.2 million, down 37.84% from the prior year.
• Research & Development eased to $788000.0 in Q2 2026 per YARW's latest filing, from $817000.0 in the prior quarter.
• Across five years, Research & Development topped out at $10.2 million in Q3 2024 and bottomed at $788000.0 in Q2 2026.
• Historically, Research & Development has averaged $4.9 million across 5 years, with a median of $4.4 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Research & Development soared 220.34% in 2024, then tumbled 86.66% in 2026.
• Over 5 years, Research & Development stood at $4.3 million in 2022, then decreased by 29.35% to $3.0 million in 2023, then jumped by 220.34% to $9.7 million in 2024, then slumped by 49.6% to $4.9 million in 2025, then tumbled by 83.86% to $788000.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $788000.0, $817000.0, and $4.9 million for Q2 2026, Q1 2026, and Q2 2025 respectively.